Colorectal cancer in the south of Israel; comparison of the clinical characteristics and survival between two periods, 1981-2 and 1986-7

Colorectal Disease

Volumn 5, Issue 2, 2003, Pages 139-144

  Lebel, E ^a   Fraser, D ^b   Fraser, G M ^a   Niv, Yaron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Postscreening effect; Screening; Stage shift; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BARIUM ENEMA; BLOOD ANALYSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HOSPITAL DEPARTMENT; HUMAN; INTESTINE ENDOSCOPY; ISRAEL; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL DECISION MAKING; MEDICAL RECORD; OCCULT BLOOD; PATIENT INFORMATION; PRIORITY JOURNAL; PROGNOSIS; RECTUM BIOPSY; RETROSPECTIVE STUDY; SEX DIFFERENCE; SIGMOIDOSCOPY; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; ISRAEL; MALE; MASS SCREENING; NEOPLASM STAGING; OCCULT BLOOD; RETROSPECTIVE STUDIES; SIGMOIDOSCOPY; SURVIVAL RATE;

EID: 0037358441     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1318.2003.00387.x     Document Type: Article

References (32)

1. BarChana M. Israel Statistics Bulletin 2002. Central Bureau of Statistics, Jerusalem, Israel Government Publication.
2. Rozen P. Screening for colorectal neoplasia in the Tel Aviv area: cumulative data 1979-89 and initial conclusions. Isr J Med Sci 1992; 28: 8-20.
3. Neugut AL. Colon cancer screening in Israel. Isr J Med Sci 1992; 28: 4-7.
4. Wingo PA, Tong T, Bolden S. Cancer Statistics 1995. CA Cancer J Clin 1995; 45: 8-30.
5. Stower MJ, Hardcastle JD. The results of 1115 patients with colorectal cancer treated over an 8 year period in a single hospital. Eur J Surg Oncol 1985; 11: 119-23.
6. Cancer. Statistics Review 1973-90. JNCI 1994; 86: 415.
7. Rozen P, Ron E, Fireman Z. The relative value of fecal occult blood tests and flexible sigmoidoscopy in screening for large bowel neoplasia. Cancer 1987; 60: 2553-8.
8. Bat L, Pines A, Niv Y et al. A community based program of colorectal screening in asymptomatic population: evaluation of screening tests and compliance. Am J Gastroenterol 1986; 81: 647-51.
9. Niv Y. Does a risk questionnaire add anything to a colorectal screening project? Report of a 3-year screening experience. J Clin Gastroenterol 1992; 15: 33-6.
10. Odes HS, Rozen P, Ron E. Screening for colorectal neoplasia: a multicenter study in Israel. Isr J Med Sci 1992; 28: 21-8.
11. Eliakim R, Shabetai O, Rachmilewitz D. Screening for fecal occult blood in Israel. Different approaches to recruitment. J Clin Gastroenterol 1988; 10: 173-5.
12. Bat L, Pines A, Ron E. Colorectal adenomatous polyps and carcinoma in Ashkenazi and non-Ashkenazi Jews in Israel. Cancer 1986; 58: 1167-71.
13. Catz I. Study in the Israeli Defense Forces - Personal communication.year.
14. Iliyasu Y, Ladipo JK, Akang EEU et al. A twenty-year review of malignant colorectal neoplasms at University College Hospital, Ibadan. Nigeria Dis Colon Rectum 1996; 39: 536-40.
15. Niv Y, Fraser G, Gold B. Screening for colonic neoplastic lesions using flexible sigmoidoscopy in employees of a nuclear research center and members of collective settlements. Isr J Med Sci 1996; 32: 1167-72.
16. Bresalier RS, Kim YS. (1993 5th edition) Malignant neoplasms of the large intestine. In: Gastrointestinal Disease (Sleisenger MH, Fordran JS, eds.), pp. 1449-93. W.B. Saunders Co, Philadelphia.
17. Snyder DN, Heston JF, Meigs JW et al. Changes in site distribution of colorectal carcinoma in Connecticut, 1940-73. Am J Dig Dis (Dig Dis Sci) 1977; 22: 791-7.
18. Mamazza J, Gordon PH. The changing distribution of large intestinal cancer. Dis Colon Rectum 1982; 25: 558-60.
19. Netscher DT, Larson GM. Colon cancer. The left to right shift and its implications. Surg Gastroenterol 1983; 2: 13-6.
20. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ 1991; 302: 1501-5.
21. McArdle CS, Wotherspoon H, Hole D et al. Colorectal cancer: a continuing problem. Gastrointestinal Cancer 1996; 1: 171-6.
22. Hakama M, Karjalainen S, Hakulinen T. Outcome based equity in the treatment of colon cancer patient in Finland. Int J Technol Assess Health Care 1989; 5: 619-30.
23. Kingston RD, Walsh S, Jeacock J. Colorectal surgeons in district general hospitals produce similar survival outcomes to their teaching hospital colleagues. review of 5 year survivals in Manchester. J R Coll Surg Edin 1992; 37: 235-7.
24. Goeckler L, Miller B, Handey B, eds. (1994) SEER Cancer Statistics Review 1973-91. National Cancer Institute, Bethesda MD.
25. Slusser SO, Liberski SM, McGarity TJ. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program. Am J Gastroenterol 1996; 91: 1563-6.
26. Curless R, French J, Williams GV et al. Comparison of gastrointestinal symptoms in colorectal carcinoma patients and community controls with respect to age. Gut 1994; 35: 1267-70.
27. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-71.
28. Kronberg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomized study of screening for colorectal cancer with fecal occult blood test. Lancet 1996; 348: 1467-71.
29. Hardcastle JD, Chamberlain JO, Robinson MHE et al. Randomized controlled trial of fecal occult blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
30. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer. JAMA 1994; 271: 1011-3.
31. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the fecal occult blood test, Hemoccult. BMJ 1998; 317: 559-65.
32. Niv Y, Lev-El M, Abuksis G, Fraser G, Tamir A. Protective effect of fecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut 2002; 50: 33-7.